Cerdulatinib (PRT2070)
CAS: 1198300-79-6
Ref. 3D-YXB30079
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
Cerdulatinib (PRT2070) is an ester hydrochloride compound with antifibrotic properties. It has been shown to inhibit the growth and proliferation of fibroblasts, which play a key role in the development of fibrosis. Cerdulatinib works by targeting alpha-tocotrienol, nintedanib, sildenafil, and other nucleophilic compounds involved in fibrotic pathways. Additionally, it has been found to inhibit fatty acid synthesis and collagen production, further contributing to its anti-fibrotic effects. Research suggests that cerdulatinib may also modulate the activity of β-catenin, a protein involved in cell signaling pathways related to fibrosis. This compound shows promise as a potential therapeutic option for various fibrotic conditions.
Propiedades químicas
Consulta técnica sobre: 3D-YXB30079 Cerdulatinib (PRT2070)
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
